AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory ...

The approval allows the company to market Imfinzi 120 mg/2.4 ml and 500 mg/10 ml in combination with gemcitabine and ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

AstraZeneca (LSE:AZN) recently experienced a weekly price move of 2% amid announcements that could have supported its ...

In March, the company had received approval from the drug regulator to import and sell sodium zirconium cyclosilicate powder ...

Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. Anurag Tiwari Orion Market Research Pvt Ltd +91 91798 28694 email us here ...

AbbVie ABBV has been expanding its oncology portfolio over the past few years. While the company was originally focused on ...

Pfizer PFE is one of the biggest players in the oncology space — a position it strengthened with the 2023 acquisition of ...

Brigade Enterprises Ltd., Deepak Fertilizers and Petrochemicals Corp., Sun Pharmaceutical Industries Ltd. and AstraZeneca ...

Executives who treat capital allocation as a CEO-level strategic discipline are best positioned to thrive in a volatile and increasingly capital-constrained environment.

GM Breweries, Hathway cable and datacom, HDFC life insurance, Just Dial, Bank of Maharashtra, ICICI Prudential Life Insurance ...

On Monday, 2054 stocks advanced, 2137 declined and 149 remained unchanged on Bombay Stock Exchange with advance decline ratio of 0.96 indicating a negative closing in the broader market.